Xilio Therapeutics (XLO) Financials: Revenue & Earnings

XLO price $8.01 0.00 0.00%

Ticker
XLO
Price
$8.01
Change
0.00 0.00%
Market cap ?
$52.71M
P/E ?
-5.09
Dividend yield ?
0.00%
Beta ?
-0.12
Sector
Healthcare
Industry
Biotechnology

Financials

2019202020212022202320242025
00000634400043766000

Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX101, a tumor-selective anti-CTLA-4 monoclonal antibody that is currently undergoing Phase 1/2 clinical trials for various solid tumors. The company also develops a range of cytokine programs, including XTX202 (a modified…

Fair value

XLO fair value Not meaningful. Price $8.01.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare XLO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.94—4.92M
2026-08-13-0.33-0.5918.69M12.72M
2026-05-12-0.58-0.6612.65M8.52M
2026-03-23-0.85-1.6813.69M10.90M
2025-11-13-1.54-0.4219.07M18.64M
2025-08-14-2.24-1.128.09M8.21M
2025-05-08-2.52-0.112.92M4.40M
2025-03-11-2.80-3.081.72M3.30M
2024-11-07-3.08-3.502.28M3.30M
2024-08-08-3.36-3.222.36M30.00M
2024-05-14-8.26-1.54—30.00M
2024-04-01-8.96-8.68—30.00M
2023-11-09-8.54-0.81——
2023-08-14-9.80-0.87——
2023-05-09-11.62-0.89——
2023-03-02-11.48-0.83——
2022-11-09-0.72-0.88——
2022-08-09-12.61-0.78——
2022-05-12-10.92-14.01——
2022-03-01-13.73-13.17——
2021-12-02-21.27-1.60——
2021-06-30-0.87———
2021-03-31-0.63———
2020-12-31-0.78———
2020-09-30-0.56———
2020-06-30-27.98———
2020-03-31-19.83———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Houvras YarivBuy105.00K$8.91935.55K
2026-09-28Houvras YarivOther0——
2026-06-11Bello Akintunde OlatokumboBuy5.00K$7.9939.95K
2026-06-11Shannon James SamuelBuy5.00K$7.9939.95K
2026-06-11Curran Daniel J.Buy5.00K$7.9939.95K
2026-06-11Xu YuanBuy5.00K$7.9939.95K
2026-06-11ROSS ROBERT W.Buy5.00K$7.9939.95K
2026-06-11Bonstein SaraBuy5.00K$7.9939.95K
2026-06-11Brennan AoifeBuy5.00K$7.9939.95K
2026-04-15Blanchard Cheryl RBuy10.00K$8.4084.00K
2026-04-15Blanchard Cheryl ROther0——
2026-03-26Shannon James SamuelBuy5.00K$8.7943.95K
2026-02-13GILEAD SCIENCES, INC.Buy3.74M$0.00374
2026-01-02Brennan Kevin M.Sell1.83K$0.641.17K
2026-01-02Frankenfield Christopher JamesSell7.03K$0.644.52K
2026-01-01Luptakova KatarinaBuy16.62K——
2026-01-01Luptakova KatarinaSell16.62K——
2026-01-01Brennan Kevin M.Sell5.00K——
2026-01-01Brennan Kevin M.Buy5.00K——
2026-01-01Frankenfield Christopher JamesSell19.38K——
2026-01-01Frankenfield Christopher JamesBuy19.38K——
2026-01-01Russo ReneBuy44.25K——
2026-01-01Russo ReneSell44.25K——
2025-12-31Luptakova KatarinaBuy451.88K$0.84380.04K
2025-12-31Brennan Kevin M.Buy95.22K$0.8480.08K
2025-12-31Frankenfield Christopher JamesBuy668.79K$0.84562.45K
2025-12-31Russo ReneBuy1.50M$0.841.26M
2025-11-26GILEAD SCIENCES, INC.Buy13.34M$0.001.33K
2025-11-26GILEAD SCIENCES, INC.Sell13.34M$0.7510.00M
2025-11-21Frankenfield Christopher JamesBuy925.00K$0.84777.92K
2025-11-21Frankenfield Christopher JamesBuy300.00K$1.50450.00K
2025-11-21Frankenfield Christopher JamesSell155.09K$1.50232.63K
2025-11-21Frankenfield Christopher JamesBuy150.00K$1.50225.00K
2025-11-21Brennan Kevin M.Buy131.70K$0.84110.76K
2025-11-21Frankenfield Christopher JamesBuy117.00K$1.50175.50K
2025-11-21Brennan Kevin M.Buy55.00K$1.0055.00K
2025-11-21Frankenfield Christopher JamesBuy45.00K$1.5067.50K
2025-11-21Frankenfield Christopher JamesBuy37.30K$1.5055.94K
2025-11-21Brennan Kevin M.Buy25.00K$1.0025.00K
2025-11-21Frankenfield Christopher JamesBuy23.79K$1.5035.68K
2025-11-21Brennan Kevin M.Buy20.00K$1.0020.00K
2025-11-21Frankenfield Christopher JamesBuy20.00K$1.5030.00K
2025-11-21Brennan Kevin M.Sell55.00K$3.17174.35K
2025-11-21Brennan Kevin M.Sell25.00K$2.7969.62K
2025-11-21Frankenfield Christopher JamesSell300.00K$2.79835.50K
2025-11-21Frankenfield Christopher JamesSell117.00K$2.69314.73K
2025-11-21Frankenfield Christopher JamesSell37.30K$16.00596.74K
2025-11-21Brennan Kevin M.Sell20.00K$1.0821.60K
2025-11-21Frankenfield Christopher JamesSell20.00K$2.1342.60K
2025-11-21Frankenfield Christopher JamesSell45.00K$12.66569.70K
2025-11-21Frankenfield Christopher JamesSell150.00K$2.75412.50K
2025-11-21Frankenfield Christopher JamesSell23.79K$6.65158.18K
2025-11-21Luptakova KatarinaBuy625.00K$0.84525.62K
2025-11-21Luptakova KatarinaBuy106.00K$1.50159.00K
2025-11-21Luptakova KatarinaBuy44.21K$1.5066.31K
2025-11-21Luptakova KatarinaBuy35.00K$1.5052.50K
2025-11-21Luptakova KatarinaBuy25.00K$1.5037.50K
2025-11-21Luptakova KatarinaBuy15.00K$1.5022.50K
2025-11-21Luptakova KatarinaSell106.00K$2.79295.74K
2025-11-21Luptakova KatarinaSell44.21K$9.69428.39K
2025-11-21Luptakova KatarinaSell15.00K$2.3735.55K
2025-11-21Luptakova KatarinaSell35.00K$2.6994.15K
2025-11-21Luptakova KatarinaSell25.00K$2.7969.62K
2025-11-21Russo ReneBuy2.08M$0.841.75M
2025-11-21Russo ReneBuy700.00K$1.501.05M
2025-11-21Russo ReneBuy473.33K$1.50710.00K
2025-11-21Russo ReneBuy350.00K$1.50525.00K
2025-11-21Russo ReneBuy239.70K$1.50359.55K
2025-11-21Russo ReneBuy150.00K$1.50225.00K
2025-11-21Russo ReneBuy135.13K$1.50202.70K
2025-11-21Russo ReneBuy100.00K$1.50150.00K
2025-11-21Russo ReneBuy50.04K$1.5075.06K
2025-11-21Russo ReneSell150.00K$12.661.90M
2025-11-21Russo ReneSell100.00K$13.831.38M
2025-11-21Russo ReneSell700.00K$2.791.95M
2025-11-21Russo ReneSell239.70K$5.511.32M
2025-11-21Russo ReneSell473.33K$5.892.79M
2025-11-21Russo ReneSell50.04K$16.00800.66K
2025-11-21Russo ReneSell350.00K$2.69941.50K
2025-11-21Russo ReneSell135.13K$11.691.58M
2025-06-17Shannon James SamuelBuy25.00K$0.6917.21K
2025-06-16Shannon James SamuelBuy45.00K$0.6930.87K
2025-06-16Russo ReneBuy36.29K$0.6824.68K
2025-06-11ROSS ROBERT W.Buy31.00K$0.6921.48K
2025-06-11Brennan AoifeBuy31.00K$0.6921.48K
2025-06-11Bonstein SaraBuy31.00K$0.6921.48K
2025-06-11Curran Daniel J.Buy31.00K$0.6921.48K
2025-06-11Clancy Paul JBuy31.00K$0.6921.48K
2025-06-11Xu YuanBuy31.00K$0.6921.48K
2025-06-11Shannon James SamuelBuy31.00K$0.6921.48K
2025-06-11Rossi ChristinaBuy31.00K$0.6921.48K
2025-06-10Bello Akintunde OlatokumboBuy62.00K$0.7043.40K
2025-06-10Bello Akintunde OlatokumboOther0——
2025-06-05GILEAD SCIENCES, INC.Buy13.34M$0.001.33K
2025-06-05GILEAD SCIENCES, INC.Buy13.34M$0.7510.00M
2025-06-05GILEAD SCIENCES, INC.Buy13.34M$0.7510.00M
2025-06-05GILEAD SCIENCES, INC.Buy13.34M$0.7510.00M
2025-04-15Russo ReneBuy190.00K$0.71135.28K
2025-04-15Frankenfield Christopher JamesBuy75.00K$0.7153.40K
2025-01-02Frankenfield Christopher JamesSell6.95K$0.986.84K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 26, holders +2 vs prior quarter. Ownership 14.21%.

HolderSharesChangeChange %Value
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC664.02K664.02KNew6.36M
ORBIMED ADVISORS LLC592.30K592.30KNew5.67M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.422.50K422.50KNew4.05M
STONEPINE CAPITAL MANAGEMENT, LLC225.99K225.99KNew2.17M
VANGUARD CAPITAL MANAGEMENT LLC178.52K54.86K+44.36%1.71M
SIO CAPITAL MANAGEMENT, LLC152.46K152.46KNew1.46M
ADAGE CAPITAL PARTNERS GP, L.L.C.111.54K111.54KNew1.07M
MERCK & CO., INC.105.98K105.98KNew1.02M
RENAISSANCE TECHNOLOGIES LLC64.15K64.15KNew614.59K
MORGAN STANLEY56.95K56.95KNew545.62K
GEODE CAPITAL MANAGEMENT, LLC39.05K39.05KNew374.17K
CITADEL ADVISORS LLC25.95K25.95KNew248.60K
VANGUARD FIDUCIARY TRUST CO22.59K-5.88K-20.65%216.45K
BRIDGEWAY CAPITAL MANAGEMENT, LLC17.54K17.54KNew168.07K
TWO SIGMA INVESTMENTS, LP14.54K14.54KNew139.33K
VELAN CAPITAL INVESTMENT MANAGEMENT LP14.29K14.29KNew136.85K
GSA CAPITAL PARTNERS LLP13.59K13.59KNew130.00K
STATE STREET CORP13.31K13.31KNew127.52K
PRELUDE CAPITAL MANAGEMENT, LLC11.60K11.60KNew111.13K
BLACKROCK, INC.8.76K8.76KNew83.89K
STEWARD PARTNERS INVESTMENT ADVISORY, LLC714714New6.84K
SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/321321New3.08K
BARCLAYS PLC115115New1.10K
KEY FINANCIAL INC5959New565
JONES FINANCIAL COMPANIES LLLP2929New262

Earnings and financials

Xilio Therapeutics, Inc. (XLO) trades at $8.01, with a market cap of $52.71M and a trailing P/E of -5.09. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
00000634400043766000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Xilio Therapeutics (XLO) Financials: Revenue & Earnings

XLO$8.010.00 0.00%

$52.71M

Market Cap

-5.09

P/E

—

Forward P/E

—

Score

Price History